loadpatents
name:-0.023638010025024
name:-0.009559154510498
name:-0.0062448978424072
Subramanian; Romesh R. Patent Filings

Subramanian; Romesh R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Subramanian; Romesh R..The latest application filed is for "muscle targeting complexes and uses thereof for treating dystrophinopathies".

Company Profile
5.8.23
  • Subramanian; Romesh R. - Framingham MA
  • Subramanian; Romesh R. - Waltham MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Muscle Targeting Complexes And Uses Thereof For Treating Dystrophinopathies
App 20220288220 - Subramanian; Romesh R. ;   et al.
2022-09-15
Methods of intravenouisly delivering anti-transferrin antibody/oligonucleotide complexes to subjects having muscular dystrophy
Grant 11,390,682 - Subramanian , et al. July 19, 2
2022-07-19
Heterologous UTR sequences for enhanced mRNA expression
Grant 11,389,546 - Burkhardt , et al. July 19, 2
2022-07-19
Muscle targeting complexes and uses thereof for treating dystrophinopathies
Grant 11,369,689 - Subramanian , et al. June 28, 2
2022-06-28
Muscle Targeting Complexes And Uses Thereof For Treating Facioscapulohumeral Muscular Dystrophy
App 20220193250 - Subramanian; Romesh R. ;   et al.
2022-06-23
Muscle Targeting Complexes And Uses Thereof For Treating Facioscapulohumeral Muscular Dystrophy
App 20220169743 - Subramanian; Romesh R. ;   et al.
2022-06-02
Muscle Targeting Complexes And Uses Thereof For Treating Dystrophinopathies
App 20220143206 - Subramanian; Romesh R. ;   et al.
2022-05-12
Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA
Grant 11,286,305 - Subramanian , et al. March 29, 2
2022-03-29
Muscle targeting complexes and uses thereof for treating dystrophinopathies
Grant 11,248,056 - Subramanian , et al. February 15, 2
2022-02-15
Muscle Targeting Complexes And Uses Thereof For Treating Dystrophinopathies
App 20220025066 - Subramanian; Romesh R. ;   et al.
2022-01-27
Muscle Targeting Complexes And Uses Thereof For Treating Facioscapulohumeral Muscular Dystrophy
App 20210380709 - Subramanian; Romesh R. ;   et al.
2021-12-09
Muscle targeting complexes and uses thereof for treating dystrophinopathies
Grant 11,168,141 - Subramanian , et al. November 9, 2
2021-11-09
Muscle Targeting Complexes And Uses Thereof For Treating Centronuclear Myopathy
App 20210322562 - Subramanian; Romesh R. ;   et al.
2021-10-21
Muscle Targeting Complexes And Uses Thereof For Treating Fibrodysplasia Ossificans Progressiva
App 20210322563 - Subramanian; Romesh R. ;   et al.
2021-10-21
Muscle Targeting Complexes And Uses Thereof For Treating Hypertrophic Cardiomyopathy
App 20210324101 - Subramanian; Romesh R. ;   et al.
2021-10-21
Muscle Targeting Complexes And Uses Thereof For Treating Pompe Disease
App 20210317226 - Subramanian; Romesh R. ;   et al.
2021-10-14
Muscle Targeting Complexes And Uses Thereof For Treating Friedreich's Ataxia
App 20210308274 - Subramanian; Romesh R. ;   et al.
2021-10-07
Muscle Targeting Complexes And Uses Thereof For Treating Dystrophinopathies
App 20210308273 - Subramanian; Romesh R. ;   et al.
2021-10-07
Muscle Targeting Complexes And Uses Thereof For Treating Myotonic Dystrophy
App 20210308272 - Subramanian; Romesh R. ;   et al.
2021-10-07
Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4
Grant 11,111,309 - Subramanian , et al. September 7, 2
2021-09-07
Muscle-targeting Complexes And Uses Thereof
App 20210261680 - Subramanian; Romesh R. ;   et al.
2021-08-26
Muscle-targeting Complexes And Uses Thereof
App 20210228730 - Subramanian; Romesh R. ;   et al.
2021-07-29
Muscle Targeting Complexes And Uses Thereof For Treating Dystrophinopathies
App 20210230290 - Subramanian; Romesh R. ;   et al.
2021-07-29
Muscle Targeting Complexes And Uses Thereof For Treating Myotonic Dystrophy
App 20210220479 - Subramanian; Romesh R. ;   et al.
2021-07-22
Muscle Targeting Complexes And Uses Thereof For Treating Facioscapulohumeral Muscular Dystrophy
App 20210206868 - Subramanian; Romesh R. ;   et al.
2021-07-08
Compositions And Methods For Modulating Mecp2 Expression
App 20210102203 - Krieg; Arthur M. ;   et al.
2021-04-08
Multimeric oligonucleotide compounds
Grant 10,704,046 - Uhlmann , et al.
2020-07-07
Modified mRNA Encoding a Glucose 6 Phosphatase and Uses Thereof
App 20200179494 - Farelli; Jeremiah ;   et al.
2020-06-11
Modified mRNA Encoding a Propionyl-CoA Carboxylase and Uses Thereof
App 20200165593 - Sobolov-Jaynes; Susan ;   et al.
2020-05-28
Multimeric Oligonucleotide Compounds
App 20190062743 - Uhlmann; Eugen ;   et al.
2019-02-28
Heterologous UTR Sequences for Enhanced mRNA Expression
App 20180353618 - Burkhardt; David H. ;   et al.
2018-12-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed